Search Results for "Genway Biotech India"

21:48 EDT 31st October 2014 | BioPortfolio

Original Source: GenWay Biotech, Inc

As a leading protein and antibody solutions provider, GenWay has a proprietary technology platform and an international network to provide our clients with solutions and applications for antibodies, recombinant proteins, full-length cDNAs, cell lines and tissue samples. We specialize in recombinant proteins and domain-specific IgY (chicken) antibodies and their applications. GenWay’s technology and expertise make high quality protein antigens that enable production of high quality antibodies. To date, ...

Matching Channels


India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

India ink colloidal carbon stain

Biotech jobs

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...


In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over ...

Matching News

India’s Dept of Biotech plans financial help for the biotech industry

Anti-cancer compounds, immunogens against H1N1, cheap recombinant human insulin, stem cell research - the Indian biotech industry is in the thick of it all. Though bubbling with innovative ideas, a la...

India encouraging opportunities for biotech innovation

In a bid to encourage new and innovative ideas for research and commercialization, the Indian government's Department of Biotechnology has invited proposals from Indian biotech companies for funding o...

BIO Provides Recommendations for Growing India’s Biotech Industry

BIO and the Association of Biotechnology Led Enterprises (ABLE) released a new report today, entitled Accelerating Growth: Forging India’s Bioeconomy, which present recommendations in support the gr...

Country Biotech Facts and Trends

ISAAA releases the revised series Biotech Country Facts and Trends. The first set in the series features the top five developing biotech countries of Brazil, Argentina, India, China, and Paraguay. Bio...

NeuClone, Serum India Sign Global Licensing Deal For 10 Biosimilars

The Serum Institute of India and NeuClone have signed a licensing agreement for the Australia-based biotech to combine its cell-line development platform with the India firm's biologics expertise to p...

Field trials of biotech mustard, brinjal permitted in India

India's environment ministry has granted Delhi University and Bejo Seeds approval to conduct field trials of their biotech mu -More- 

Education on hygiene and sanitation is the need of the hour in India

Even after 66 years of independence, 60% of the rural population of India has no toilet facilities, although the figure is less than 9% in urban India.1 2 India launched the Nirmal Bharat Abhiyan... ...

Gilead: Still 50% Upside Left In The Stock

By Bret Jensen:I have been receiving a lot of comments recently on my articles here on SeekingAlpha and in my mailbag about the largest position in my portfolio, Gilead Sciences (NASDAQ:GILD). The sha...

Matching PubMed Articles

Future and Training of Craniofacial Surgery in India.

Craniofacial surgery, in the strictest sense, is the surgery of structures above and behind the maxilla. Craniofacial surgery is not new to India and has been around for more than 4 decades now since ...

University biotech patenting 2013.

Erratum: University biotech patenting 2013.

Public biotech 2013-the numbers.

Benchmarking biotech and pharmaceutical product development.

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement